Recent research focusing on Tirzepatide at a dosage of 40mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate the lon